727 Topline safety and efficacy update of SUPLEXA-101, a first-in-human, single agent study of SUPLEXA therapeutic cells in 28 patients with metastatic solid tumours

類似資料

• 727 Topline safety and efficacy update of SUPLEXA-101, a first-in-human, single agent study of SUPLEXA therapeutic cells in 28 patients with metastatic solid tumours
  著者:: Rohit Joshi, 等
  出版事項: (2023-11-01)
• ‘Āmirī (m. 381/992)
  著者:: Terrier, Mathieu, 等
  出版事項: (2025)
• Introdução (Vol. 38.1/2024)
  著者:: Gonçalo Fernandes, 等
  出版事項: (2024-07-01)
• 2 (p. 34 et 381)
  著者:: Perrot, Nicolas, 等
  出版事項: (2004)
• Research progress on the immunomodulatory mechanism of Treg cells in autologous guided bone regeneration
  著者:: Bao-Fu Yu
  出版事項: (2026-07-01)